MICRONOR

Micronor Adverse Events Reported to the FDA Over Time

How are Micronor adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Micronor, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Micronor is flagged as the suspect drug causing the adverse event.

Most Common Micronor Adverse Events Reported to the FDA

What are the most common Micronor adverse events reported to the FDA?

Drug Exposure During Pregnancy	46 (6.43%)
Pregnancy On Oral Contraceptive	45 (6.29%)
Vaginal Haemorrhage	41 (5.73%)
Inappropriate Schedule Of Drug Admi...	20 (2.8%)
Headache	19 (2.66%)
Abdominal Pain	17 (2.38%)
Suppressed Lactation	13 (1.82%)
Drug Exposure Via Breast Milk	12 (1.68%)
Weight Decreased	12 (1.68%)
Depression	11 (1.54%)
Abortion Spontaneous	10 (1.4%)
	Show More
Drug Dose Omission	10 (1.4%)
Abdominal Distension	9 (1.26%)
Dizziness	8 (1.12%)
Drug Interaction	8 (1.12%)
Migraine	8 (1.12%)
Anxiety	7 (.98%)
Metrorrhagia	7 (.98%)
Nervousness	7 (.98%)
Uterine Spasm	7 (.98%)
Asthenia	6 (.84%)
Lupus-like Syndrome	6 (.84%)
Medication Error	6 (.84%)
Product Quality Issue	6 (.84%)
Smear Vaginal Abnormal	6 (.84%)
Syncope	6 (.84%)
Tremor	6 (.84%)
Vision Blurred	6 (.84%)
Abdominal Discomfort	5 (.7%)
Nausea	5 (.7%)
Pulmonary Embolism	5 (.7%)
Accidental Drug Intake By Child	4 (.56%)
Arthritis	4 (.56%)
Breast Cancer	4 (.56%)
Breast Pain	4 (.56%)
Ectopic Pregnancy	4 (.56%)
Hyperlipidaemia	4 (.56%)
Mood Altered	4 (.56%)
Myalgia	4 (.56%)
Premenstrual Syndrome	4 (.56%)
Psoriatic Arthropathy	4 (.56%)
Rash	4 (.56%)
Somnolence	4 (.56%)
Weight Increased	4 (.56%)
Abdominal Pain Upper	3 (.42%)
Amenorrhoea	3 (.42%)
Anaemia	3 (.42%)
Back Pain	3 (.42%)
Cerebrovascular Accident	3 (.42%)
Cyst	3 (.42%)
Dysmenorrhoea	3 (.42%)
Fatigue	3 (.42%)
Grand Mal Convulsion	3 (.42%)
Haemorrhage	3 (.42%)
Hospitalisation	3 (.42%)
Hypotension	3 (.42%)
International Normalised Ratio Incr...	3 (.42%)
Irritability	3 (.42%)
Lactose Intolerance	3 (.42%)
Musculoskeletal Stiffness	3 (.42%)
Off Label Use	3 (.42%)
Pelvic Pain	3 (.42%)
Photophobia	3 (.42%)
Premature Baby	3 (.42%)
Superior Sagittal Sinus Thrombosis	3 (.42%)
Transverse Sinus Thrombosis	3 (.42%)
Urinary Tract Infection	3 (.42%)
Abortion Spontaneous Incomplete	2 (.28%)
Acne	2 (.28%)
Arthralgia	2 (.28%)
Bladder Discomfort	2 (.28%)
Cardiac Arrest	2 (.28%)
Cholelithiasis	2 (.28%)
Completed Suicide	2 (.28%)
Contusion	2 (.28%)
Convulsion	2 (.28%)
Cystitis	2 (.28%)
Cystitis Noninfective	2 (.28%)
Depressed Mood	2 (.28%)
Depression Suicidal	2 (.28%)
Diarrhoea	2 (.28%)
Emotional Disorder	2 (.28%)
Episcleritis	2 (.28%)
Failure To Thrive	2 (.28%)
Gallbladder Operation	2 (.28%)
Gastrooesophageal Reflux Disease	2 (.28%)
Hypertension	2 (.28%)
Hypertensive Crisis	2 (.28%)
Hypothyroidism	2 (.28%)
Intra-uterine Death	2 (.28%)
Jaundice Cholestatic	2 (.28%)
Joint Swelling	2 (.28%)
Limb Reduction Defect	2 (.28%)
Loss Of Consciousness	2 (.28%)
Macular Degeneration	2 (.28%)
Menopausal Symptoms	2 (.28%)
Menstrual Disorder	2 (.28%)
Muscular Weakness	2 (.28%)
Panic Attack	2 (.28%)
Pyrexia	2 (.28%)
Rash Pruritic	2 (.28%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Micronor, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Micronor is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Micronor

What are the most common Micronor adverse events reported to the FDA?

Medication Errors	54 (7.55%)
Pregnancy, Labour, Delivery And Pos...	48 (6.71%)
Chemical Injury And Poisoning	47 (6.57%)
Gastrointestinal Signs	46 (6.43%)
Vulvovaginal Disorders	43 (6.01%)
Headaches	27 (3.78%)
Neurological	27 (3.78%)
Menstrual Cycle And Uterine Bleedin...	21 (2.94%)
Breast	20 (2.8%)
Anxiety Disorders	18 (2.52%)
Physical Examination Topics	17 (2.38%)
	Show More
Abortions And Stillbirth	15 (2.1%)
Depressed Mood Disorders	15 (2.1%)
Joint	14 (1.96%)
Therapeutic And Nontherapeutic Effe...	14 (1.96%)
Infections - Pathogen Unspecified	10 (1.4%)
Central Nervous System Vascular	9 (1.26%)
Epidermal And Dermal Conditions	9 (1.26%)
Musculoskeletal And Connective Tiss...	9 (1.26%)
Muscle	8 (1.12%)
Reproductive Organ And Breast Inves...	8 (1.12%)
Vision	8 (1.12%)
Connective Tissue Disorders	7 (.98%)
Hematology Investigations	7 (.98%)
Mood Disorders	7 (.98%)
Therapeutic Procedures And Supporti...	7 (.98%)
Uterine, Pelvic And Broad Ligament	7 (.98%)
Gastrointestinal Motility And Defec...	6 (.84%)
Movement Disorders	6 (.84%)
Product Quality Issues	6 (.84%)
Seizures	6 (.84%)
Urinary Tract Signs	6 (.84%)
Breast Neoplasms Malignant And Unsp...	5 (.7%)
Injuries	5 (.7%)
Maternal Complications Of Pregnancy	5 (.7%)
Pulmonary Vascular	5 (.7%)
Cardiac Arrhythmias	4 (.56%)
Decreased And Nonspecific Blood Pre...	4 (.56%)
Embolism And Thrombosis	4 (.56%)
Endocrine Investigations	4 (.56%)
Hepatic And Hepatobiliary	4 (.56%)
Lipid Metabolism	4 (.56%)
Ocular Structural Change, Deposit A...	4 (.56%)
Skin Appendage Conditions	4 (.56%)
Vascular Hemorrhagic	4 (.56%)
Vascular Hypertensive	4 (.56%)
Anemias Nonhemolytic And Marrow Dep...	3 (.42%)
Appetite And General Nutritional	3 (.42%)
Food Intolerance Syndromes	3 (.42%)
Inner Ear And Viiith Cranial Nerve	3 (.42%)
Neonatal And Perinatal Conditions	3 (.42%)
Ocular Infections, Irritations And ...	3 (.42%)
Ocular Sensory Symptoms	3 (.42%)
Ovarian And Fallopian Tube	3 (.42%)
Reproductive Tract	3 (.42%)
Tissue	3 (.42%)
Angiedema And Urticaria	2 (.28%)
Bladder And Bladder Neck Disorders	2 (.28%)
Body Temperature Conditions	2 (.28%)
Electrolyte And Fluid Balance Condi...	2 (.28%)
Gallbladder	2 (.28%)
Glucose Metabolism Disorders	2 (.28%)
Hepatobiliary Therapeutic Procedure...	2 (.28%)
Menopause And Related Conditions	2 (.28%)
Musculoskeletal And Connective Tiss...	2 (.28%)
Neurological, Special Senses And Ps...	2 (.28%)
Ocular Hemorrhages And Vascular	2 (.28%)
Reproductive Neoplasms Female Benig...	2 (.28%)
Suicidal And Self-injurious Behavio...	2 (.28%)
Thyroid Gland	2 (.28%)
Allergic Conditions	1 (.14%)
Cardiac And Vascular Investigations	1 (.14%)
Cardiac Disorder Signs	1 (.14%)
Coagulopathies And Bleeding Diathes...	1 (.14%)
Demyelinating	1 (.14%)
Eye	1 (.14%)
Gastrointestinal Conditions	1 (.14%)
Gastrointestinal Hemorrhages	1 (.14%)
Gastrointestinal Therapeutic Proced...	1 (.14%)
Gastrointestinal Ulceration And Per...	1 (.14%)
Gender Related Factors	1 (.14%)
Hypothalamus And Pituitary Gland	1 (.14%)
Lifestyle Issues	1 (.14%)
Maternal Complications Of Labour An...	1 (.14%)
Miscellaneous And Site Unspecified ...	1 (.14%)
Obstetric And Gynecological Therape...	1 (.14%)
Personality Disorders	1 (.14%)
Procedural And Device Related Injur...	1 (.14%)
Psychiatric	1 (.14%)
Psychiatric And Behavioural Symptom...	1 (.14%)
Respiratory	1 (.14%)
Retina, Choroid And Vitreous Hemorr...	1 (.14%)
Sexual Function And Fertility	1 (.14%)
Skin And Subcutaneous Tissue	1 (.14%)
Skin Vascular Abnormalities	1 (.14%)
Sleep Disorders	1 (.14%)
Tongue Conditions	1 (.14%)
Toxicology And Therapeutic Drug Mon...	1 (.14%)
Upper Respiratory Tract Disorders	1 (.14%)
White Blood Cell	1 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Micronor, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Micronor is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.